We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1B
AUM Growth
-$10.2M
Cap. Flow
-$19.8M
Cap. Flow %
-1.98%
Top 10 Hldgs %
3.73%
Holding
2,077
New
647
Increased
422
Reduced
386
Closed
620

Top Buys

Rank Stock Value
1
WEN icon
Wendy's
WEN
+$4.1M
2
DMC
Del Monte Corp
DMC
+$3.08M
3
SONO icon
Sonos
SONO
+$2.84M
4
IDXX icon
Idexx Laboratories
IDXX
+$2.8M
5
JBSS icon
John B. Sanfilippo & Son
JBSS
+$2.73M

Sector Composition

Rank Sector Weight
1 Technology 15.64%
2 Consumer Discretionary 14.23%
3 Healthcare 13.56%
4 Financials 11.82%
5 Industrials 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZH
1376
Zhihu
ZH
$279M
$106K 0.01%
15,664
-35,348
-69% -$232K
ATOM icon
1377
Atomera
ATOM
$212M
$103K 0.01%
11,784
-16,688
-59% -$132K
NKTR icon
1378
Nektar Therapeutics
NKTR
$2.58B
$103K 0.01%
11,899
-125
-1% -$1.33K
VRAY
1379
DELISTED
ViewRay, Inc.
VRAY
$100K 0.01%
283,053
+89,248
+46% +$92.5K
ALXO icon
1380
ALX Oncology
ALXO
$283M
$96K 0.01%
+12,730
New +$83.3K
LGHL
1381
Lion Group Holding
LGHL
$831K
$96K 0.01%
3
+2
+200% +$90.7K
TWOU
1382
DELISTED
2U Inc
TWOU
$92K 0.01%
760
-5,748
-88% -$764K
THCH icon
1383
TH International
THCH
$56.7M
$91K 0.01%
+6,372
New +$114K
NIU
1384
Niu Technologies
NIU
$193M
$90K 0.01%
22,527
-44,602
-66% -$173K
XERS icon
1385
Xeris Biopharma Holdings
XERS
$1.37B
$87K 0.01%
33,215
-282,810
-89% -$720K
TWKS
1386
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
$87K 0.01%
11,498
+1,472
+15% +$10.9K
AIV
1387
Aimco
AIV
$383M
$86K 0.01%
+10,118
New +$82.3K
OPTU
1388
Optimum Communications Inc
OPTU
$301M
$86K 0.01%
+28,640
New +$81.3K
CAPR icon
1389
Capricor Therapeutics
CAPR
$237M
$86K 0.01%
+17,890
New +$78.6K
SYRS
1390
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$86K 0.01%
27,460
+10,613
+63% +$34.1K
ABUS icon
1391
Arbutus Biopharma
ABUS
$915M
$85K 0.01%
36,923
-1,237
-3% -$3.22K
AFMD
1392
DELISTED
Affimed
AFMD
$85K 0.01%
14,132
+10,251
+264% +$82.2K
OCFT
1393
DELISTED
OneConnect Financial Technology
OCFT
$85K 0.01%
25,686
-4,382
-15% -$20.2K
ME
1394
DELISTED
23andMe Holding Co
ME
$84K 0.01%
+2,400
New +$95.6K
GROV icon
1395
Grove Collaborative
GROV
$45.4M
$83K 0.01%
47,058
-2,766
-6% -$6.09K
SDIG
1396
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$82K 0.01%
+19,614
New +$135K
OPEN icon
1397
Opendoor
OPEN
$3.38B
$79K 0.01%
+20,420
New +$44.3K
GENI icon
1398
Genius Sports
GENI
$2.11B
$78K 0.01%
+12,643
New +$63.4K
KLRS
1399
Kalaris Therapeutics
KLRS
$96.8M
$75K 0.01%
955
-1,088
-53% -$103K
RAIN
1400
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$74K 0.01%
+61,302
New +$307K

Similar funds

GSA Capital Partners's Q2 2023 Portfolio in Review

As of Q2 2023, GSA Capital Partners held 2,077 positions worth $1B, down 1% from $1.01B the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners's Q2 2023 filing shows 647 new, 422 increased, 386 reduced and 620 closed positions. Its largest new stake was Sonos: 160,082 shares worth $2.61M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $7.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • GSA Capital Partners's largest Q2 2023 buy was Sonos: 160,082 shares worth $2.61M.
  • GSA Capital Partners added most to Wendy's in Q2 2023, an estimated $4.1M increase.
  • GSA Capital Partners's biggest Q2 2023 reduction was Arlo Technologies, cutting an estimated $3.67M.
  • GSA Capital Partners fully exited iShares 1-3 Year Treasury Bond ETF in Q2 2023, selling an estimated $7.8M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $1B portfolio in Q2 2023.
  • GSA Capital Partners opened 647 new positions and closed 620 in Q2 2023.
  • GSA Capital Partners's portfolio value fell 1% quarter-over-quarter to $1B.

Based on GSA Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.